Table 3. Internal validity (methodological and parasitological) of included trials.
Trial | Methodological Assessment (Jadad Score)§ | Parasitological Assessment¥ | |||||||
Randomized€? | Double-Blinded?® | A Description of Withdrawals or Dropouts? | Total Jadad Score | Description | Adequate | Repeated | Interobserver | Total | |
Alizadeh, 2006 [39] | 1 | 0 | 1 | 2 | 2 | 0 | 3 | 0 | 5 |
Yereli, 2004 [41] | 1 | 0 | 1 | 2 | 2 | 8 | 3 | 0 | 13 |
Karabay, 2004 [40] | 1 | 0 | 1 | 2 | 2 | 0 | 3 | 0 | 5 |
Rodríguez-García, 1996 [44] | 1 | 0 | 0 | 1 | 2 | 3 | 3 | 0 | 8 |
Misra, 1995 [29] | 1 | 0 | 1 | 2 | 2 | 3 | 3 | 0 | 8 |
Romero-Cabello, 1995 [42] | 1 | 0 | 1 | 2 | 2 | 3 | 3 | 0 | 8 |
Dutta, 1994 [45] | 1 | 0 | 1 | 2 | 2 | 0 | 3 | 0 | 5 |
Hall, 1993a,b [43] | 2 | 0 | 1 | 3 | 2 | 4 | 3 | 0 | 9 |
§Range 0–5 (5 exemplifies articles with the highest quality).
¥Range 0–15, (15 indicates most optimal diagnostic procedure employed).
€Represents generation of allocation sequence.
®Represents allocation concealment.